Fingerprint
Dive into the research topics of 'Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Research output: Contribution to journal › Article › peer-review